{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T11:29:40Z","timestamp":1753356580372,"version":"3.40.5"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"46","license":[{"start":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T00:00:00Z","timestamp":1700179200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,17]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Severe community-acquired pneumonia (sCAP) is characterized by severe symptoms and a poor prognosis, especially with the recent global impact of novel coronavirus in recent years. The use of glucocorticoids in sCAP is currently a subject of debate. To evaluate the clinical efficacy and safety of glucocorticoids and provide guidance for their rational use in clinical practice, we conducted this study.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched PubMed, Web of Science, and China National Knowledge Infrastructure using the following search terms: \u201cpneumonia\u201d, \u201cpneumonias\u201d, \u201cPulmonary Inflammation\u201d, \u201cPulmonary Inflammations\u201d, \u201cLung Inflammation\u201d, and \u201cLung Inflammations\u201d. The primary outcomes included mortality and the length of hospital stay. The secondary outcomes included the duration of mechanical ventilation, duration of vasoactive drug use, gastrointestinal bleeding, and multiple infections. The Cochrane Collaboration was used to assess the risk of bias of the included studies. Stata\/MP14 was used for meta-analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>These studies contained information on 1252 patients who received glucocorticoids and 1280 patients who did not. Meta-analysis showed that there was no difference in terms of mortality [risk ratio (RR)\u2005=\u20050.93, 95% confidence interval (CI): 0.81\u20131.07, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">&gt;<\/jats:italic>\u2005.05], gastrointestinal bleeding (RR\u2005=\u20051.38, 95% CI: 0.83\u20132.30, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">&lt;<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">.05<\/jats:italic>), multiple infections (RR\u2005=\u20051.17, 95% CI: 0.90\u20131.53, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">&gt;<\/jats:italic>\u2005.05) and length of hospital stay (mean difference [MD]\u2005=\u2005\u22120.87, 95% CI: \u22122.35 to 0.61, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">&gt;<\/jats:italic>\u2005.05) between the hormonal and nonhormonal groups. However, there was a significant difference in the duration of mechanical ventilation (MD\u2005=\u2005\u22121.54; 95% CI, \u22121.89 to \u22121.12, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">&lt;<\/jats:italic>\u2005\n                                 <jats:italic toggle=\"yes\">.05<\/jats:italic>) and the duration of use of vasoactive drugs (MD\u2005=\u2005\u221214.09, 95% CI: \u221215.72 to \u221212.46, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u2005.05).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Glucocorticoids reduced the duration of mechanical ventilation duration and vasoactive drug use in sCAP patients without increasing the risk of adverse events including hyperglycemia and multiple infections. However, there was no significant difference in mortality or length of hospital stay in sCAP patients between glucocorticoid and non-glucocorticoid groups. Glucocorticoids could be recommended for patients with sCAP with respiratory failure or hemodynamic instability.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036047","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T09:27:11Z","timestamp":1701163631000},"page":"e36047","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Clinical value of glucocorticoids for severe community-acquired pneumonia: A systematic review and meta-analysis based on randomized controlled trials"],"prefix":"10.1097","volume":"102","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7297-2883","authenticated-orcid":false,"given":"Biao","family":"Peng","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Li","sequence":"additional","affiliation":[{"name":"Medical College of Jishou University, Jishou, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minwei","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Critical Care Medicine, Anhua County People\u2019s Hospital, Anhua, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xianghui","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Hengyang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Hao","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feifei","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ZhiChao","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5113-4004","authenticated-orcid":false,"given":"Da","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"1","article-title":"Deaths leading causes for 2015.","volume":"66","author":"Heron","year":"2017","journal-title":"Natl Vital Stat Rep"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.mcna.2018.12.008","article-title":"Community-acquired pneumonia and hospital-acquired pneumonia.","volume":"103","author":"Lanks","year":"2019","journal-title":"Med Clin North Am"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"e0191721","DOI":"10.1371\/journal.pone.0191721","article-title":"Severe community-acquired pneumonia: characteristics and prognostic factors in ventilated and non-ventilated patients.","volume":"13","author":"Ferrer","year":"2018","journal-title":"PLoS One"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area.","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1056\/NEJMp058068","article-title":"Preparing for the next pandemic.","volume":"352","author":"Osterholm","year":"2005","journal-title":"N Engl J Med"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARs patients.","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"e44110","DOI":"10.1371\/journal.pone.0044110","article-title":"Corticosteroid treatment ameliorates acute lung injury induced by 2009 swine origin influenza A (H1N1) virus in mice.","volume":"7","author":"Li","year":"2012","journal-title":"PLoS One"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19.","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect"},{"key":"R9-20250504","first-page":"145","article-title":"The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China.","volume":"41","year":"2020","journal-title":"Chin J Epidemiol"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08114","article-title":"The AP-1 transcription factor Batf controls T(H)17 differentiation.","volume":"460","author":"Schraml","year":"2009","journal-title":"Nature"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ncb1909","article-title":"Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion.","volume":"11","author":"Rodier","year":"2009","journal-title":"Nat Cell Biol"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.yexcr.2017.09.041","article-title":"T cell responses in senior patients with community-acquired pneumonia related to disease severity.","volume":"361","author":"Bian","year":"2017","journal-title":"Exp Cell Res"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.cytogfr.2017.04.002","article-title":"Glucocorticoid resistance as a major drive in sepsis pathology.","volume":"35","author":"Dendoncker","year":"2017","journal-title":"Cytokine Growth Factor Rev"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1111\/crj.12674","article-title":"Diagnosis and treatment of community-acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical Association.","volume":"12","author":"Cao","year":"2018","journal-title":"Clin Respir J"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.21037\/jtd.2017.05.31","article-title":"South African guideline for the management of community-acquired pneumonia in adults.","volume":"9","author":"Boyles","year":"2017","journal-title":"J Thorac Dis"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.3389\/fimmu.2018.02446","article-title":"Sepsis and nosocomial infection: patient characteristics, mechanisms, and modulation.","volume":"9","author":"Denstaedt","year":"2018","journal-title":"Front Immunol"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/01.shk.0000235130.82363.ed","article-title":"Pneumonia after cecal ligation and puncture: a clinically relevant \u201ctwo-hit\u201d model of sepsis.","volume":"26","author":"Muenzer","year":"2006","journal-title":"Shock"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.88","article-title":"Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial.","volume":"313","author":"Torres","year":"2015","journal-title":"JAMA"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.2020.17021","article-title":"Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial.","volume":"324","author":"Tomazini","year":"2020","journal-title":"JAMA"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"e373","DOI":"10.1093\/cid\/ciaa1177","article-title":"Methylprednisolone as adjunctive therapy for patients hospitalized with coronavirus disease 2019 (COVID-19; Met COVID): a randomized, double-blind, phase IIb, placebo-controlled trial.","volume":"72","author":"Jeronimo","year":"2021","journal-title":"Clin Infect Dis"},{"key":"R21-20250504","first-page":"28","article-title":"Observation on the clinical efficacy of glucocorticoid in the treatment of patients with severe community -acquired pneumonia complicated with septic shock.","volume":"59","author":"Han","year":"2021","journal-title":"China Mod Doct"},{"key":"R22-20250504","first-page":"1054","article-title":"Clinical application of glucocorticoids in the treatment of acute respiratory distress syndrome caused by severe community-acquired pneumonia.","volume":"43","author":"Kang","year":"2014","journal-title":"Shaanxi Med J"},{"key":"R23-20250504","first-page":"2014","article-title":"Therapeutic effect of glucocorticoids in patients with severe community-acquired pneumonia complicated with septic shock.","volume":"27","author":"Li","year":"2018","journal-title":"Henan Med Res"},{"key":"R24-20250504","first-page":"780","article-title":"Value of glucocorticoid steroids in the treatment of patients with severe community-acquired pneumonia complicated with septic shock.","volume":"28","author":"Li","year":"2016","journal-title":"Chin Crit Care Med"},{"key":"R25-20250504","first-page":"138","article-title":"Therapeutic effect of glucocorticoids on elderly severe community-acquired pneumonia.","volume":"14","author":"Li","year":"2020","journal-title":"Chin J Mod Drug Appl"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1007\/s00134-022-06684-3","article-title":"Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.","volume":"48","author":"Meduri","year":"2022","journal-title":"Intensive Care Med"},{"key":"R27-20250504","first-page":"1171","article-title":"Clinical efficacy of glucocorticoids in the treatment of severe community acquired pneumonia and its impact on CRP.","volume":"18","author":"Sui","year":"2013","journal-title":"J Clin Pulm Med"},{"key":"R28-20250504","first-page":"6923","article-title":"Clinical value of glucocorticoids in the treatment of elderly severe community-acquired pneumonia.","volume":"34","author":"Tong","year":"2014","journal-title":"Chin J Gerontol"},{"key":"R29-20250504","first-page":"856","article-title":"Therapeutic value of glucocorticoids in severe community-acquired pneumonia.","volume":"31","author":"Xu","year":"2011","journal-title":"Chin J Pract Intern Med"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000512063","article-title":"Early use of corticosteroid may prolong SARs-CoV-2 shedding in non-intensive care unit patients with COVID-19 pneumonia: a multicenter, single-blind, randomized control trial.","volume":"100","author":"Tang","year":"2021","journal-title":"Respiration"},{"key":"R31-20250504","first-page":"16","article-title":"Clinical analysis of low-dose glucocorticoid in the treatment of severe community acquired pneumonia.","volume":"13","author":"Yang","year":"2018","journal-title":"China Pract Med"},{"key":"R32-20250504","first-page":"456","article-title":"Clinical analysis of glucocorticoid-adjuvant antibiotics in the treatment of elderly patients with severe community-acquired pneumonia.","volume":"29","author":"Zhu","year":"2017","journal-title":"Mod Pract Med"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1056\/NEJMoa1500245","article-title":"Community-acquired pneumonia requiring hospitalization among US adults.","volume":"373","author":"Jain","year":"2015","journal-title":"N Engl J Med"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"e382","DOI":"10.1016\/j.ijid.2011.02.002","article-title":"One-year outcomes of community-acquired and healthcare-associated pneumonia in the Veterans affairs healthcare system.","volume":"15","author":"Hsu","year":"2011","journal-title":"Int J Infect Dis"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis.","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19.","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1016\/j.chest.2020.07.089","article-title":"International perspective on the New2019 American Thoracic Society\/Infectious Diseases Society of America Community-acquired pneumonia guideline.","volume":"158","author":"Pletz","year":"2020","journal-title":"Chest"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/cid\/ciaa601","article-title":"Early short course corticosteroids in hospitalized patients with COVID-19.","volume":"71","author":"Fadel","year":"2020","journal-title":"Clin Infect Dis"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China.","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern Med"},{"key":"R40-20250504","first-page":"147","article-title":"Low-dose corticosteroid therapy does not delay viral clearance in patients with COVID-19.","volume":"81","author":"Fang","year":"2020","journal-title":"J Infect"},{"key":"R41-20250504","doi-asserted-by":"crossref","first-page":"e16239","DOI":"10.1097\/MD.0000000000016239","article-title":"Efficacy and safety of glucocorticoids in the treatment of severe community-acquired pneumonia: a meta-analysis.","volume":"98","author":"Jiang","year":"2019","journal-title":"Medicine (Baltim)"},{"key":"R42-20250504","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1056\/NEJMoa2215145","article-title":"Hydrocortisone in severe community-acquired pneumonia.","volume":"388","author":"Dequin","year":"2023","journal-title":"N Engl J Med"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"R96","DOI":"10.1186\/cc10103","article-title":"Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial.","volume":"15","author":"Fern\u00e1ndez-Serrano","year":"2011","journal-title":"Crit Care"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1530\/EJE-16-0969","article-title":"Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality.","volume":"176","author":"Bancos","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with ad-renal insufficiency (DREAM): a single-blind, randomised controlled trial.","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R46-20250504","first-page":"815","article-title":"Impact of systemic corticosteroids on the clinical outcomes in patients with severe community-acquired pneumonia: a multi-center retrospective study.","volume":"31","author":"Chen","year":"2019","journal-title":"Chin Crit Care Med"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.200905-0808OC","article-title":"Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial.","volume":"181","author":"Snijders","year":"2010","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036047","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T08:03:05Z","timestamp":1746345785000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036047"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,17]]},"references-count":47,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036047","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,11,17]]}}}